AU2007299043B2 - Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field - Google Patents

Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field Download PDF

Info

Publication number
AU2007299043B2
AU2007299043B2 AU2007299043A AU2007299043A AU2007299043B2 AU 2007299043 B2 AU2007299043 B2 AU 2007299043B2 AU 2007299043 A AU2007299043 A AU 2007299043A AU 2007299043 A AU2007299043 A AU 2007299043A AU 2007299043 B2 AU2007299043 B2 AU 2007299043B2
Authority
AU
Australia
Prior art keywords
stem cells
treatment
pharmaceutical composition
mammals
adult stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007299043A
Other languages
English (en)
Other versions
AU2007299043A1 (en
Inventor
Alessandra Gambacurta
Marco Polettini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thankstem Srl
Original Assignee
Thankstem Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thankstem Srl filed Critical Thankstem Srl
Publication of AU2007299043A1 publication Critical patent/AU2007299043A1/en
Assigned to THANKSTEM SRL reassignment THANKSTEM SRL Request for Assignment Assignors: SALES ENGINEERING AG
Application granted granted Critical
Publication of AU2007299043B2 publication Critical patent/AU2007299043B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
AU2007299043A 2006-09-20 2007-09-11 Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field Ceased AU2007299043B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000498A ITRM20060498A1 (it) 2006-09-20 2006-09-20 Metodo di espansione di cellule staminali adulte da sangue periferico e relativi usi in campo medico
ITRM2006A000498 2006-09-20
PCT/EP2007/059531 WO2008034740A1 (en) 2006-09-20 2007-09-11 Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field

Publications (2)

Publication Number Publication Date
AU2007299043A1 AU2007299043A1 (en) 2008-03-27
AU2007299043B2 true AU2007299043B2 (en) 2013-06-27

Family

ID=38126399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007299043A Ceased AU2007299043B2 (en) 2006-09-20 2007-09-11 Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field

Country Status (20)

Country Link
US (2) US8263400B2 (enExample)
EP (1) EP2076588B1 (enExample)
JP (1) JP5340941B2 (enExample)
KR (1) KR101570446B1 (enExample)
CN (1) CN101553565B (enExample)
AU (1) AU2007299043B2 (enExample)
BR (1) BRPI0715036A2 (enExample)
CA (1) CA2663072C (enExample)
DK (1) DK2076588T3 (enExample)
EA (1) EA019305B1 (enExample)
ES (1) ES2435080T3 (enExample)
HR (1) HRP20131104T1 (enExample)
IL (1) IL197575A (enExample)
IT (1) ITRM20060498A1 (enExample)
MX (1) MX2009003059A (enExample)
PL (1) PL2076588T3 (enExample)
RS (1) RS53039B (enExample)
SI (1) SI2076588T1 (enExample)
WO (1) WO2008034740A1 (enExample)
ZA (1) ZA200901748B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132116B2 (en) * 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
ITUD20080058A1 (it) * 2008-03-18 2009-09-19 Thankstem S R L Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali
EP2424527B8 (en) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
KR101202836B1 (ko) * 2010-08-27 2012-11-20 서울대학교산학협력단 세포응집을 이용한 인간 혈액 유래 혈구 세포괴의 유도와 이를 이용한 혈중 성체줄기세포 및 전구세포의 증폭방법 및 상기의 방법에 의해 제조된 줄기세포
AU2012212254A1 (en) * 2011-01-31 2013-09-19 Royal Medical Group, Pllc Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
BE1020480A5 (nl) * 2012-10-01 2013-11-05 Global Stem Cell Technology Werkwijze voor de isolatie van mesenchymale stamcellen uit bloed van zoogdieren, en gebruik ervan.
KR20170002568A (ko) * 2014-05-09 2017-01-06 땡스템 에스알엘 전혈로부터의 성체 줄기세포 증대 방법
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2016204230A1 (ja) * 2015-06-17 2016-12-22 仁幸 小林 幹細胞投与方法、競走馬または競技馬の症状改善方法、注射用容器および幹細胞注射セット
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
AU2017281631B2 (en) 2016-06-23 2023-06-15 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
CN113924361A (zh) * 2019-05-22 2022-01-11 善克思腾(股份)责任有限公司 从全血中扩增成体干细胞的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003083092A1 (en) * 2002-03-28 2003-10-09 Blasticon Biotechnologische Forschung Gmbh Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
WO2004043990A2 (en) * 2002-11-07 2004-05-27 University Of Chicago Human stem cell materials and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1436843A (zh) * 2002-02-08 2003-08-20 刘颉 脐血造血干细胞的制作方法
CN1667119A (zh) * 2004-03-11 2005-09-14 中国人民解放军第二军医大学 一种成体干细胞及其培养方法和用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003083092A1 (en) * 2002-03-28 2003-10-09 Blasticon Biotechnologische Forschung Gmbh Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
WO2004043990A2 (en) * 2002-11-07 2004-05-27 University Of Chicago Human stem cell materials and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Zhao Y et al, Proceedings of the National Academy of Sciences, 2003, 100(5):2426-2431 *

Also Published As

Publication number Publication date
PL2076588T3 (pl) 2014-01-31
WO2008034740A1 (en) 2008-03-27
DK2076588T3 (da) 2013-11-11
US20120308535A1 (en) 2012-12-06
CN101553565B (zh) 2015-05-06
JP2010504083A (ja) 2010-02-12
CA2663072A1 (en) 2008-03-27
HRP20131104T1 (hr) 2013-12-20
IL197575A0 (en) 2011-08-01
RS53039B (sr) 2014-04-30
IL197575A (en) 2013-06-27
ES2435080T3 (es) 2013-12-18
ITRM20060498A1 (it) 2008-03-21
SI2076588T1 (sl) 2013-12-31
BRPI0715036A2 (pt) 2013-05-28
KR20090074044A (ko) 2009-07-03
EA019305B1 (ru) 2014-02-28
EP2076588A1 (en) 2009-07-08
US20100068189A1 (en) 2010-03-18
EP2076588B1 (en) 2013-08-21
ZA200901748B (en) 2010-03-31
MX2009003059A (es) 2009-04-01
US8263400B2 (en) 2012-09-11
CA2663072C (en) 2016-01-19
KR101570446B1 (ko) 2015-11-27
AU2007299043A1 (en) 2008-03-27
HK1138315A1 (en) 2010-08-20
JP5340941B2 (ja) 2013-11-13
EA200970294A1 (ru) 2009-10-30
CN101553565A (zh) 2009-10-07

Similar Documents

Publication Publication Date Title
CA2663072C (en) Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field
Hu et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells
JP2010504083A5 (enExample)
ES2550456T3 (es) Uso de una composición que contiene células madre mesenquimatosas derivadas de sangre de cordón umbilical humano para inducir diferenciación y proliferación de células precursoras neurales o células madre neurales a células neurales
US20060159666A1 (en) Method of potentiating inflammatory and immune modulation for cell and drug therapy
Sun et al. Application of human umbilical cord mesenchymal stem cells in rat spinal cord injury model
JP2022016722A (ja) 胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
US8500712B2 (en) Kit for collecting blood, preferably peripheral blood, for the production of stem cells
CN106011173A (zh) 一种抑制神经二次损伤的人少突胶质祖细胞的制备方法及其试剂盒与应用
CN113583948B (zh) Cd200+亚群脐带间充质干细胞的培养方法及其所用的培养基
EA035104B1 (ru) Способ размножения взрослых стволовых клеток из цельной крови
JP2024069733A (ja) 心不全およびその併発疾患の治療法、治療剤および診断法。
US10765706B2 (en) Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
HK1138315B (en) Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field
RU2413523C2 (ru) Способ лечения посттравматической энцефалопатии
RU2286160C1 (ru) Способ лечения травматических повреждений спинного мозга
US20210085713A1 (en) Compositions and methods for treating stroke
CN116669747A (zh) 具有正常核型的新型nr1 es源性神经干细胞及其用途

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: THANKSTEM SRL

Free format text: FORMER APPLICANT(S): SALES ENGINEERING AG

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired